The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Christian Parr

Cardiff University

UK

[email]@cf.ac.uk

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Cardiff University, UK. 2010
  • Metastasis and Angiogenesis Research Group, School of Medicine, Cardiff University, Cardiff, United Kingdom. 2005 - 2007
  • University Department of Surgery, University of Wales College of Medicine, Cardiff, UK. 2000 - 2004

References

  1. Hepatocyte growth factor activation inhibitors - therapeutic potential in cancer. Parr, C., Sanders, A.J., Jiang, W.G. Anticancer. Agents. Med. Chem (2010) [Pubmed]
  2. Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients. Parr, C., Sanders, A.J., Davies, G., Martin, T., Lane, J., Mason, M.D., Mansel, R.E., Jiang, W.G. Clin. Cancer Res. (2007) [Pubmed]
  3. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells. Parr, C., Jiang, W.G. Int. J. Cancer (2006) [Pubmed]
  4. Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients. Parr, C., Gan, C.H., Watkins, G., Jiang, W.G. Angiogenesis (2006) [Pubmed]
  5. Placenta growth factor is over-expressed and has prognostic value in human breast cancer. Parr, C., Watkins, G., Boulton, M., Cai, J., Jiang, W.G. Eur. J. Cancer (2005) [Pubmed]
  6. The hepatocyte growth factor regulatory factors in human breast cancer. Parr, C., Watkins, G., Mansel, R.E., Jiang, W.G. Clin. Cancer Res. (2004) [Pubmed]
  7. The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer. Parr, C., Watkins, G., Jiang, W.G. Int. J. Mol. Med. (2004) [Pubmed]
  8. Quantitative analysis of lymphangiogenic markers in human colorectal cancer. Parr, C., Jiang, W.G. Int. J. Oncol. (2003) [Pubmed]
  9. Hepatocyte growth factor activators, inhibitors and antagonists and their implication in cancer intervention. Parr, C., Jiang, W.G. Histol. Histopathol. (2001) [Pubmed]
  10. Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells. Parr, C., Hiscox, S., Nakamura, T., Matsumoto, K., Jiang, W.G. Int. J. Cancer (2000) [Pubmed]
 
WikiGenes - Universities